Reitan Colleen F - Net Worth and Insider Trading
Reitan Colleen F Net Worth
The estimated net worth of Reitan Colleen F is at least $690,311 dollars as of 2024-12-03. Reitan Colleen F is the Director of Myriad Genetics Inc and owns about 42,533 shares of Myriad Genetics Inc (MYGN) stock worth over $690,311. Details can be seen in Reitan Colleen F's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Reitan Colleen F has not made any transactions after 2024-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Reitan Colleen F
Reitan Colleen F Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Reitan Colleen F owns 2 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , and Myriad Genetics Inc (MYGN) .
Click here to see the complete history of Reitan Colleen F’s form 4 insider trades.
Insider Ownership Summary of Reitan Colleen F
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2018-06-01 | director |
| MYGN | Myriad Genetics Inc | 2024-09-03 | director |
Reitan Colleen F Latest Holdings Summary
Reitan Colleen F currently owns a total of 1 stock. Reitan Colleen F owns 42,533 shares of Myriad Genetics Inc (MYGN) as of September 3, 2024, with a value of $690,311.
Latest Holdings of Reitan Colleen F
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MYGN | Myriad Genetics Inc | 2024-09-03 | 42,533 | 16.23 | 690,311 |
Holding Weightings of Reitan Colleen F
Reitan Colleen F Form 4 Trading Tracker
According to the SEC Form 4 filings, Reitan Colleen F has made a total of 1 transactions in Myriad Genetics Inc (MYGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Myriad Genetics Inc is the sale of 46,012 shares on September 3, 2024, which brought Reitan Colleen F around $1 Million.
Insider Trading History of Reitan Colleen F
- 1
Reitan Colleen F Trading Performance
Reitan Colleen F Ownership Network
Reitan Colleen F Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Reitan Colleen F is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Tolga Tanguler , CMO & EVP Dev & Med Affairs Pushkal Garg , and Chief Financial Officer Jeffrey V. Poulton .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Reitan Colleen F made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 57,750 shares made by Yvonne Greenstreet , a net sale of 11,986 shares made by Pushkal Garg , and a net sale of 7,321 shares made by Jeffrey V. Poulton .
In summary, during the past 3 months, insiders sold 13,052 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 13,052 shares. During the past 18 months, 262,180 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 262,180 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Reitan Colleen F Mailing Address
Above is the net worth, insider trading, and ownership report for Reitan Colleen F. You might contact Reitan Colleen F via mailing address: 300 Third Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
